This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Biofrontera Future Growth
Future criteria checks 5/6
Key information
44.5%
Earnings growth rate
42.1%
EPS growth rate
| Pharmaceuticals earnings growth | 19.4% |
| Revenue growth rate | 22.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | n/a |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 40 | 3 | 1 | 2 | 1 |
| 12/31/2023 | 31 | 0 | -4 | -3 | 1 |
| 12/31/2022 | 26 | -38 | -9 | -9 | 1 |
| 6/30/2022 | 31 | 10 | 33 | 33 | N/A |
| 3/31/2022 | 30 | 15 | N/A | N/A | N/A |
| 12/31/2021 | 29 | 38 | 30 | 30 | N/A |
| 9/30/2021 | 28 | -16 | N/A | N/A | N/A |
| 6/30/2021 | 27 | -16 | -8 | -7 | N/A |
| 3/31/2021 | 29 | -12 | N/A | N/A | N/A |
| 12/31/2020 | 30 | -13 | -4 | -3 | N/A |
| 9/30/2020 | 33 | -17 | N/A | N/A | N/A |
| 6/30/2020 | 33 | -22 | -14 | -12 | N/A |
| 3/31/2020 | 31 | -10 | N/A | N/A | N/A |
| 12/31/2019 | 31 | -7 | -35 | -33 | N/A |
| 9/30/2019 | 26 | 1 | N/A | N/A | N/A |
| 6/30/2019 | 26 | 8 | -29 | -28 | N/A |
| 3/31/2019 | 23 | -8 | N/A | N/A | N/A |
| 12/31/2018 | 21 | -9 | -14 | -13 | N/A |
| 9/30/2018 | 19 | -14 | -13 | -13 | N/A |
| 6/30/2018 | 16 | -15 | -12 | -12 | N/A |
| 3/31/2018 | 14 | -16 | N/A | N/A | N/A |
| 12/31/2017 | 12 | -16 | -14 | -13 | N/A |
| 9/30/2017 | 11 | -18 | -16 | -16 | N/A |
| 6/30/2017 | 9 | -16 | -16 | -16 | N/A |
| 3/31/2017 | 8 | -14 | -15 | -15 | N/A |
| 12/31/2016 | 6 | -11 | -11 | -10 | N/A |
| 9/30/2016 | 4 | -9 | -9 | -8 | N/A |
| 6/30/2016 | 4 | -7 | -6 | -6 | N/A |
| 3/31/2016 | 4 | -9 | N/A | -8 | N/A |
| 12/31/2015 | 4 | -11 | N/A | -10 | N/A |
| 9/30/2015 | 4 | -12 | N/A | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: B8FE's forecast earnings growth (44.5% per year) is above the savings rate (-0.01%).
Earnings vs Market: B8FE's earnings (44.5% per year) are forecast to grow faster than the German market (9.8% per year).
High Growth Earnings: B8FE's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: B8FE's revenue (22% per year) is forecast to grow faster than the German market (3.8% per year).
High Growth Revenue: B8FE's revenue (22% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if B8FE's Return on Equity is forecast to be high in 3 years time